GXO vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

GXO

65.2
AI Score
VS
GXO Wins

DOCS

45.8
AI Score

Investment Advisor Scores

GXO

65score
Recommendation
HOLD

DOCS

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GXO DOCS Winner
Forward P/E 15.1286 19.1571 GXO
PEG Ratio 1.2607 0.5895 DOCS
Revenue Growth 4.3% 7.3% DOCS
Earnings Growth -4.0% -51.9% GXO
Tradestie Score 65.2/100 45.8/100 GXO
Profit Margin 1.0% 25.5% DOCS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GXO 1M: -12.1% · 3M: -2.4% DOCS 1M: +25.0% · 3M: +28.0%

Current Technical Phase

GXO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $46.35

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.1% over 20 days), RSI 58

RSI (14): 58.2 · Price: $25.53

Fundamentals Snapshot

Metric GXO DOCS
Market Cap
Forward P/E 12.9 15.6
Trailing P/E 40.9 30.5
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.0% 0.2%
EPS 1.11 0.85
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GXO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.